Arcutis Biotherapeutics Inc

{ "date": [ "202612", "202712", "202812", "202912", "203012" ], "revenue_estimate": [ 498.73, 645.62, 783.18, 919.46, 1055.82 ], "ebit_estimate": [ 22.96, 142.57, 261.16, 358.7, 472.2 ], "ebitda_estimate": [ 67.21, 183.32, 287.3, null, null ], "net_income_estimate": [ 19.22, 140.25, 263.56, 352.88, 415.03 ], "per_share_eps_estimate": [ 0.12, 0.99, 1.81, 2.48, 2.91 ], "eps_nri_estimate": [ 0.15, 1.03, 1.84, 2.48, 2.91 ], "dividend_estimate": [ null, null, null, null, null ], "book_value_per_share_estimate": [ 1.98, 3.45, 5.61, null, null ], "pretax_income_estimate": [ 28.07, 149.21, 265.01, 369.58, 490.16 ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null ], "roe_estimate": [ 16.89, 46.67, 46.56, null, null ], "gross_margin_estimate": [ 90.5, 90.67, 91, 91, 91 ], "operating_cash_flow_estimate": [ null, null, null, null, null ], "pettm_estimate": [ 237.09, 27.94, 15.33, 11.19, 9.54 ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "27.88", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": 27.88, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": 55.91, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": 0.27, "future_operating_cash_flow_per_share_estimate_growth": null }

{ "date": [ "202606", "202609", "202612", "202703", "202706", "202709", "202712" ], "revenue_estimate": [ 117.75, 129.81, 146.2, 137.73, 152.25, 165, 177.5 ], "ebit_estimate": [ 3, 9, 20.05, 5.5, 19.7, 30.5, 41.7 ], "ebitda_estimate": [ 20.47, 31.11, 38.81, 26.56, null, null, null ], "net_income_estimate": [ 2.26, 8.26, 16.23, 5.3, 18.05, 27.55, 37.3 ], "per_share_eps_estimate": [ 0.02, 0.07, 0.13, 0.03, 0.14, 0.2, 0.3 ], "eps_nri_estimate": [ 0.03, 0.07, 0.14, 0.03, 0.14, 0.2, 0.3 ], "dividend_estimate": [ null, null, null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null, null, null ], "pretax_income_estimate": [ 2.3, 8.33, 16.41, 5.75, 20, 30.95, 42.35 ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null, null, null ], "roe_estimate": [ null, null, null, null, null, null, null ], "gross_margin_estimate": [ 91, 91.25, 90.5, 91, 91, 91, 91 ], "operating_cash_flow_estimate": [ null, null, null, null, null, null, null ], "pettm_estimate": [ 115.1, 76.84, 55.93, 41.71, null, null, null ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "27.88", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": 27.88, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": 55.91, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": 0.27, "future_operating_cash_flow_per_share_estimate_growth": null }